Literature DB >> 28190133

Depressive symptoms moderate the relationship between medication regimen complexity and objectively measured medication adherence in adults with heart failure.

Carly M Goldstein1,2, Emily C Gathright3,4, John Gunstad4, Mary A Dolansky5, Joseph D Redle6, Richard Josephson7,8, Shirley M Moore5, Joel W Hughes4,6.   

Abstract

Patients with heart failure (HF) take many medications to manage their HF and comorbidities, and 20-50% experience depression. Depressed individuals with more complex medication regimens may be at greater risk for poor adherence. The aim of this study was to assess depressive symptoms as a moderator of the relationship between medication regimen complexity and medication adherence in an observational study of patients with HF. In hierarchical linear regression with the final sample of 299, the interaction of medication regimen complexity and depressive symptoms predicted medication adherence, p < .05. For individuals with higher levels of depressive symptoms [1 standard deviation (SD) above the mean], more regimen complexity was associated with lower adherence. For individuals with low (1 SD below the mean) or average levels of depressive symptoms, regimen complexity was unrelated to medication adherence. Care management strategies, including pillboxes and caregiver involvement, may be valuable in HF patients with depression.

Entities:  

Keywords:  Cardiovascular diseases; Depressive symptoms; Heart failure; Medication adherence; Self-care

Mesh:

Year:  2017        PMID: 28190133      PMCID: PMC5873320          DOI: 10.1007/s10865-017-9829-z

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  48 in total

Review 1.  Medication adherence and persistence: a comprehensive review.

Authors:  Kem P Krueger; Bruce A Berger; Bill Felkey
Journal:  Adv Ther       Date:  2005 Jul-Aug       Impact factor: 3.845

Review 2.  Medication adherence: a call for action.

Authors:  Hayden B Bosworth; Bradi B Granger; Phil Mendys; Ralph Brindis; Rebecca Burkholder; Susan M Czajkowski; Jodi G Daniel; Inger Ekman; Michael Ho; Mimi Johnson; Stephen E Kimmel; Larry Z Liu; John Musaus; William H Shrank; Elizabeth Whalley Buono; Karen Weiss; Christopher B Granger
Journal:  Am Heart J       Date:  2011-09       Impact factor: 4.749

3.  How does depression influence diabetes medication adherence in older patients?

Authors:  Amy M Kilbourne; Charles F Reynolds; Chester B Good; Susan M Sereika; Amy C Justice; Michael J Fine
Journal:  Am J Geriatr Psychiatry       Date:  2005-03       Impact factor: 4.105

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 5.  Depression as a predictor of adherence to adjuvant endocrine therapy (AET) in women with breast cancer: a systematic review and meta-analysis.

Authors:  Brent T Mausbach; Richard B Schwab; Scott A Irwin
Journal:  Breast Cancer Res Treat       Date:  2015-06-16       Impact factor: 4.872

6.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

7.  Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity.

Authors:  Jeffrey S Gonzalez; Steven A Safren; Enrico Cagliero; Deborah J Wexler; Linda Delahanty; Eve Wittenberg; Mark A Blais; James B Meigs; Richard W Grant
Journal:  Diabetes Care       Date:  2007-05-29       Impact factor: 19.112

8.  Major depression and medication adherence in elderly patients with coronary artery disease.

Authors:  R M Carney; K E Freedland; S A Eisen; M W Rich; A S Jaffe
Journal:  Health Psychol       Date:  1995-01       Impact factor: 4.267

Review 9.  Medication adherence: its importance in cardiovascular outcomes.

Authors:  P Michael Ho; Chris L Bryson; John S Rumsfeld
Journal:  Circulation       Date:  2009-06-16       Impact factor: 29.690

10.  A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes.

Authors:  Steven A Safren; Jeffrey S Gonzalez; Deborah J Wexler; Christina Psaros; Linda M Delahanty; Aaron J Blashill; Aleksandra I Margolina; Enrico Cagliero
Journal:  Diabetes Care       Date:  2013-10-29       Impact factor: 19.112

View more
  2 in total

Review 1.  Medication Complexity Among Older Adults with HF: How Can We Assess Better?

Authors:  Min Ji Kwak; Monica Cheng; Parag Goyal; Dae Hyun Kim; Scott L Hummel; Abhijeet Dhoble; Ashish Deshmukh; Rajender Aparasu; Holly M Holmes
Journal:  Drugs Aging       Date:  2022-10-13       Impact factor: 4.271

2.  Synergistic Effect of Disease Severity, Anxiety Symptoms and Elderly Age on the Quality of Life of Outpatients with Heart Failure.

Authors:  José Henrique Cunha Figueiredo; Gláucia Maria Moraes de Oliveira; Basílio Bragança Pereira; Ana Elisa Bastos Figueiredo; Emília Matos Nascimento; Marcelo Iorio Garcia; Sergio Salles Xavier
Journal:  Arq Bras Cardiol       Date:  2020-01       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.